Price $82.97 |
Market Cap
15.79B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
20.3
|
P/B
3.92
|
P/S
8.53
|
Dividend %
-
|
|
P/CF
27.6
|
P/FCF
879.9
|
Op. Cash Flow
156.1K
|
FCF
0.1
|
|
Op. Margin
-0.10%
|
Net Margin
45.70%
|
ROE
25.00%
|
ROI
-0.70%
|
|
ROA
16.30%
|
EPS Growth
-
|
Current Ratio
2.1
|
Debt/Equity
15.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AcelRx Pharmaceuticals Inc (ACRX) | $2.18 | - | - | 123.5M | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.22 | - | - | 4.7M | Strong Buy |
| AmerisourceBergen Corp. (ABC) | $106.52 | - | 1.80% | 19.8B | Strong Buy |
| Boston Scientific Corporation (BSX) | $36.33 | - | - | 50.9B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.68 | - | - | 19.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
